Previous close | 8.50 |
Open | N/A |
Bid | 6.40 |
Ask | 7.70 |
Strike | 22.50 |
Expiry date | 2024-05-17 |
Day's range | 8.50 - 8.50 |
Contract range | N/A |
Volume | |
Open interest | 7 |
NovoCure Limited (NASDAQ:NVCR) Q1 2024 Earnings Call Transcript May 2, 2024 NovoCure Limited beats earnings expectations. Reported EPS is $-0.36134, expectations were $-0.43. NVCR isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day and thank you for standing by. […]
Comprehensive Analysis of NovoCure's First Quarter Financial Performance
NovoCure (NVCR) delivered earnings and revenue surprises of 16.28% and 5.30%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?